Literature DB >> 22072584

Peripheral nerve reconstruction with collagen tubes filled with denatured autologous muscle tissue in the rat model.

Ulf Dornseifer1, Andreas M Fichter, Stefan Leichtle, Andrew Wilson, Angelika Rupp, Karsten Rodenacker, Milomir Ninkovic, Edgar Biemer, Hans-Günther Machens, Kaspar Matiasek, Nikolaos A Papadopulos.   

Abstract

Conventional nerve conduits lack cellular and extracellular guidance structures critical for bridging larger defects. In this study, an exogenous matrix for axonal regeneration was provided by pretreated muscle tissue. In 24 rats, 14-mm sciatic nerve segments were resected and surgically reconstructed using one of the following methods: autograft (AG); bovine type I collagen conduit; (MDM) collagen tube filled with modified denatured autologous muscle tissue. For 8 weeks, functional regeneration was evaluated by footprint and video gait analysis. Evaluation was complemented by electrophysiology, as well as qualitative and quantitative structural assessment of nerves and target muscles. Group AG was superior both structurally and functionally, showing higher axon counts, a more normal gait pattern, and less severe muscle atrophy. Fiber quality (fiber size and myelin thickness) was highest in group MDM, possibly related to the myelin-producing effect of muscular laminin. However, axon count was lowest in this group, and ultrastructural analysis of the denatured muscle tissue showed areas of incomplete denaturation that had acted as a mechanical barrier for regenerating axons. In light of these results, the often advocated use of muscular exogenous matrix for peripheral nerve reconstruction is reviewed in the literature, and its clinical application is critically discussed. In conclusion, combined muscle tubes may have a positive influence on nerve fiber maturation. However, muscle pretreatment is not without risks, and denaturation processes need to be further refined.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072584     DOI: 10.1002/micr.20926

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  7 in total

1.  The development of a normalization method for comparing nerve regeneration effectiveness among different graft types.

Authors:  Wei Chang; Jeffrey DeVince; Gabriella Green; Munish Bhupendra Shah; Michael S Johns; Yan Meng; Xiaojun Yu
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

2.  Cauda equina repair in the rat: Part 3. Axonal regeneration across Schwann cell-Seeded collagen foam.

Authors:  Samuel J Mackenzie; Juneyoung L Yi; Amit Singla; Thomas M Russell; Donna J Osterhout; Blair Calancie
Journal:  Muscle Nerve       Date:  2017-08-13       Impact factor: 3.217

3.  Comparison of repair of peripheral nerve transection in predegenerated muscle with and without a vein graft.

Authors:  Jamshid Mohammadi; Hamdollah Delaviz; Bahram Mohammadi; Hamoun Delaviz; Parastou Rad
Journal:  BMC Neurol       Date:  2016-11-22       Impact factor: 2.474

4.  Preclinical evaluations of acellular biological conduits for peripheral nerve regeneration.

Authors:  I-Chien Liao; Hua Wan; Shijie Qi; Cunqi Cui; Paarun Patel; Wendell Sun; Hui Xu
Journal:  J Tissue Eng       Date:  2013-02-28       Impact factor: 7.813

Review 5.  Past, Present, and Future of Nerve Conduits in the Treatment of Peripheral Nerve Injury.

Authors:  Aikeremujiang Muheremu; Qiang Ao
Journal:  Biomed Res Int       Date:  2015-09-27       Impact factor: 3.411

6.  Sciatic nerve repair using adhesive bonding and a modified conduit.

Authors:  Xiangdang Liang; Hongfei Cai; Yongyu Hao; Geng Sun; Yaoyao Song; Wen Chen
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

7.  Chitosan Tubes Enriched with Fresh Skeletal Muscle Fibers for Primary Nerve Repair.

Authors:  Giulia Ronchi; Benedetta Elena Fornasari; Alessandro Crosio; Claudia Alexandra Budau; Pierluigi Tos; Isabelle Perroteau; Bruno Battiston; Stefano Geuna; Stefania Raimondo; Giovanna Gambarotta
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.